Conventional disease-modifying agents in rheumatoid arthritis – a review of their current use and role in treatment algorithms
Despite the development of targeted therapies, conventional synthetic disease-modifying antirheumatic drugs (csDMARDs) remain the cornerstone of treatment of rheumatoid arthritis (RA). A literature search was conducted on treatment recommendations and relevant papers regarding new insights on thera...
Enregistré dans:
| Auteurs principaux: | , , |
|---|---|
| Format: | article |
| Langue: | EN |
| Publié: |
Termedia Publishing House
2020
|
| Sujets: | |
| Accès en ligne: | https://doaj.org/article/e0bc9db1a4a145ef8336bc1ddecacc68 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|